Related Experiment Video
Updated: Apr 18, 2026

11:48
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
12.2K
Overlapping MHC class I/II Epitopes Program cDC1-like Differentiation of Monocyte-Derived Dendritic Cells via mTORC1
S B Amanya1, A Murthy1,2, N Bisht1
1Department of Pathology and Immunology, Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030.
Biorxiv : the Preprint Server for Biology
|April 17, 2026
Summary
Viral infections enhance type 1 immunity via homologous MHC epitopes, reprogramming dendritic cells. This process, governed by mTORC1, offers potential for cancer immunotherapy development.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Viral infections induce type 1 immunity through monocyte-derived dendritic cells (moDCs).
- Homologous MHC class I and II epitopes, common in intracellular infections, enhance this immune response.
- The precise mechanism by which homologous epitopes influence moDC polarization remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which homologous MHC epitopes polarize moDCs.
- To investigate the role of mTORC1 in this process.
- To explore the implications for cancer immunotherapy.
Main Methods:
- Loading moDCs with homologous MHC epitopes.
- Inhibiting the mTORC1 pathway.
- Analyzing gene expression related to type 1 immunity and cDC1 phenotype.
- Evaluating clinical moDC vaccine products.
Main Results:
- moDCs loaded with homologous MHC epitopes acquired a cDC1-like phenotype.
- This phenotype acquisition was dependent on mTORC1 signaling.
- mTORC1 inhibition resulted in NF-κB-mediated IL-12 expression and type I immune gene induction.
- Clinical moDC vaccine products with enforced antigenic homology showed an enhanced cDC1-like gene signature.
Conclusions:
- Homologous MHC epitopes induce a cDC1-like phenotype in moDCs via an mTORC1-dependent pathway.
- This mechanism represents a novel form of immune governance.
- The findings suggest potential applications for homologous antigen strategies in cancer immunotherapy.
Keywords:
Type 1 conventional dendritic cellType 1 immunitycancer immunotherapyimmune regulationmajor histocompatibility complexmonocyte-derived dendritic cellMore Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
17.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K
Antigens Involved in Adaptive Immunity
1.9K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.9K

